MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery. The minimally invasive MitraClip procedure is effective in both functional and degenerative mitral regurgitation. The procedure is performed percutaneously in a cath lab and the device is removable and repositionable. These important attributes contribute to the safety of this procedure. Diligent patient selection is an important element to ensure success. Data from 119 patients in the International MitraBridge Registry on critically ill patients on a transplant list showed procedural success was achieved in 87.5% of cases, and 30-day survival was 100%. Repeat hospitalisations are avoided after the MitraClip procedure as compared to conventional surgery, making it economical in the long run and patients are able to recover and resume life in a very short span of time.” Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Group said, “As one of the few hospit
Hide player controls
Hide resume playing